Cardiology Conferences | Cardiologists Meetings | Heart Failure Meetings | European Cardiology Conferences 2019 | Japan | Europe | USA | Asia-pacific

Theme: Investigating Cardiological Research and Healthcare Innovations

Euro Cardiology 2019

Conference Prograqm

Renowned Speakers

Heinz-Peter Schultheiss
Institute of Cardiac and Diagnostic Therapy
Germany

Kevin A. Courville
Prevail Heart Clinics
USA

Rainer G. H. Moosdorf
University Hospital of Giessen and Marburg GmbH
Germany

Marco PicichÃ¨
San Bortolo Hospital
Italy

Gheorge Cerin
San Gaudenzio Clinic
Italy

Gian Luca Martinelli
San Gaudenzio Clinic
Italy

Guido Lanzillo
Policlinic of Monza
Italy

Takeo Tedoriya
Ageo Central General Hospital
Japan

Jochen Senges
Stiftung Institut fÃ¼r Herzinfarktforschung Ludwigshafen
Germany

Chiara Mozzini
University of Verona
Italy

Tamara Feygin
University of Pennsylvania
USA

Ingrid E. Dumitriu
St. Georgeâ€™s University of London
UK

Peter Ott
Sarver Heart Center
USA

Imre Janszky
Norwegian University of Science and Technology
Norway

Maliheh Nazari-Jahantigh
Institute for Cardiovascular Prevention - LMU
Germany

Ryan Del Rosario Buendia
St. Lukeâ€™s Medical Center
Philippines

Abdulraouf MZ Jijeh
King Abdulaziz Cardiac Center
Saudi Arabia

John P Breinholt
University of Texas McGovern Medica
USA

Vaiva Patamsyte
Lithuanian University of Health Sciences
Lithuania

Kenan Abdurrahman Kara
Yeditepe University Hospital
Turkey

Hitoshi Adachi
Gunma Prefectural Cardiovascular Center
Japan

Marco Diena
Clinica San Gaudenzio
Italy

Waldo Emerson Pinheiro Daniel
Federal University of RN
Brazil

Wajih Maazouzi
University Medical Center of Rabat
Morocco

Suzanne L. Tinsley

USA

Jan Piek
Academic Medical Center, Amsterdam
Netherlands

John J Wang
Academic Medical Center, Amsterdam
USA

Issam A Mikati

USA

Philippe Chevalier
Louis Pradel Cardiology Hospital of Lyon
France

Jean-Pierre Usdin
American Hospital of Paris
France

Robert Skalik
Medical University of WrocÅ‚aw
Poland

Fabiola B Sozzi
University of Milan
Italy

Fekry ElDeeb
Zulekha Hospitals
UAE

Aris Lacis
University Children Hospital
Latvia

Samer Ellahham
Sheikh Khalifa Medical City
UAE

Omar Kamel Hallak
American Hospital Dubai
UAE

Nabil Naser
Sarajevo University
Bosnia and Herzegovina

Manotosh Panja
The BM Birla Heart Research Centre
India

Baris Cankaya
Marmara University Hospital
Turkey

Ashraf Reda
Menofiya University
Egypt

Sameh Salama
Cairo University
Egypt

Atef Elbahry
Port Fouad Hospital â€“Port-Said
Egypt

K. K. Talwar
Max Heart Institute
India

Marie Vazquez Morgan
LSU Health School of Allied Health Professions
USA

Daniel Lichtenstein
Ambroise-ParÃ© Hospital
France

Katriina Aalto-SetÃ¤lÃ¤
University of Tampere
Finland

Anna Maria Fratta Pasini
University of Verona
Italy

Galal Eldin Nagib-Elkilany
Gulf Medical University
UAE

Sibel Catirli Enar
Turkiye Hospital
Turkey

Alex Mota Benevides
Federal University of ABC
Brazil

Reda Mohamed
Benha University
Egypt

Peter Ofner
National Institute of Cardiology
Hungary

Guy Hugues Fontaine
Groupe Hospitalier PitiÃ©-SalpÃªtriÃ¨re
France

Jozsef Balla
University of Debrecen
Hungary

Miguel Angel Maluf
SÃ£o Paulo Federal University
Brazil

Pablo Rodenas
Rosario Gamma Group
Argentina

LeonÃ© Malan
North-West University
South Africa

Regina CÃ©lia Spadari
Universidade Federal de Sao Paulo
Brazil

Sophia Chew
General Hospital
Singapore

Anna Rekhviashvili
Clinical Hospital
Georgia

Sivaraj J. Govindasamy
National Heart Centre
Singapore

Alexander ManchÃ©
Mater Dei Hospital
Malta

Ketevan Chagunava
Tbilisi State University
Georgia

Omiros Chalvatzoulis
Interbalkan Medical Center
Greece

Yoshinori Enomoto
Kimitsu Chuo Hospital
Japan

Georgiy Korobeynikov
National University of Physical Education and Sport, Kiev
Ukraine

Peter P Karpawich
Wayne State University
USA

Salwa Ahmed Elgebaly
Nour Heart Institue
USA

Ersoz Gonca
Bulent Ecevit University
Turkey

Riccardo Turri
Mirano General Hospital
Italy

Rajeev Agarwala
Jaswant Rai Speciality Hospital
India

Sara Badia
Universitari Germans Trias i Pujol
Spain

Maria Kalliopi Konstantinidou
Harefield Hospital
UK

Elisabet Berastegui
Hospital Universitari Germans Trias i Pujol
Spain

Nattapong Thaiyanurak
Siriraj Hospital-Mahidol University
Thailand

Aleksandra SzyliÅ„ska
Pomeranian Medical University in Szczecin
Poland

Ahmed Mostafa
Ain Shams University
Egypt

Farrah Pervaiz
Armed Forces Institute of Cardiology and National Institute of Heart Disease
Pakistan

Javier Cabo Salvador
UDIMA, UNIA & US Universities
Spain

Anton Cherepov
Research Institute of Space Medicine, Federal Research Clinical Center
Russia

Euro Cardiology 2019

Welcome Message

Welcome to Eurocardiology 2019

The 32nd European Cardiology Conference will be held in Zurich, Switzerland during October 24-26, 2019 organized by Eurocardiology 2019. Cardiology Conferences will lay a platform for scientists, world-class professors, and cardiologists to discuss an approach for cardiovascular diseases. International Cardiology Conferences is designed to provide diverse and current education that will keep medical professionals alongside of the issues affecting the diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and vascular devices have been developed which helped for the treatment of cardiac disorders, replacement and repair therapy. Robotic surgeries for the cardiac and vascular surgery which has been favorable in a wide range. Cardiology conferences 1000+ CME Global events every year across the globe with support from 1000+ more scientific societies and Publishes 500 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The field incorporates therapeutic analysis and treatment of coronary vein infection, Cardiac imperfections, valvular coronary illness, heart disappointment and electrophysiology. Cardiology is concerned with the characteristic usefulness of the heart and discrepancy from a normal heart. Numerous issues include the heart itself yet some are outside of the heart.

Euro Cardiology 2019 welcomes the, Professors, Research scholars, Industrial Professionals, Cardiac surgeons, Cardiologists, physicians, and student delegates from cardiology and healthcare sectors to be a part of it.

Why to attend???

The 32^nd European Cardiology Conference is among the World’s leading Cardiology Conference. This Euro Cardiology 2019 will coordinate appears, disperse information, and meet with recurring pattern and potential investigators and get name affirmation at this 3-day event. Broadly acclaimed speakers, the most recent frameworks, methodologies, and the most current updates in Cardiology field are indications of this conference. This year conference will comprises of major sessions designed to offer comprehensive sessions that address current issues in various field of Cardiovascular & cardiac diseases. The benefits provided to the attendees are:

Certificates will be provided to all speakers, delegates and students
Opportunity to meet world’s renowned at this event
Keynote forums by Prominent Physicians & Professors
Best platform for Global business and networking opportunities
Oral/Poster presentations by Young Researchers
Best poster award for students

Target Audience:

Directors, CEO’s of Organizations
Cardiac Surgeons
Cardio-thoracic Surgeons
Physicians
Noble laureates in Health Care and Medicine
Cardiac Nurses & Nurse Practitioners
Cardiology Associations and Societies
Business Professionals
Doctors
Cardiologists
Vascular Surgeons
Medical colleges and universities
Professors
Researchers & Scientists
Anesthesiologists
Medicine Experts
Manufacturing Medical Devices Companies
PhD Scholars

Zurich, Switzerland:

Zurich is a leading global city and among the world’s largest financial centers despite having a relatively low population. The city is home to a large number of financial institutions and banking giants. Most of Switzerland’s research and development centers are concentrated in Zurich and the low tax rates attract overseas companies to set up their headquarters there. Many museums and art galleries can be found in the city, including the Swiss National Museum and the Kunsthaus. According to several surveys from 2006 to 2008, Zurich was named the city with the best quality of life in the world as well as the wealthiest city in Europe.

The Economist Intelligence Unit’s Global Liveability Ranking sees Zurich ranks among the top ten most liveable cities in the world. Zurich has, depending on the definition used, an oceanic climate (Koppen Cfb), with four distinct seasons. Decisive for the climate of Zurich are both the winds from westerly directions, which often result in precipitation and, on the other hand, the Bise (east or north-east wind), which is usually associated with high-pressure situations, but cooler weather phases with temperatures lower than the average. The Foehn wind, which plays an important role in the northern alpine valleys also, has some impact on Zurich.

The city of Zurich is among the world leaders in protecting the climate by following a manifold approach. Public transport is extremely popular in Zurich, and its inhabitants use public transport in large numbers. Zurich city highlights are The nation’s biggest lakes—Geneva, Constance (Bodensee), and Maggiore— straddle the French, German-Austrian, and Italian outskirts, individually. The Rhine, safe from Basel toward the North Sea, is the key inland waterway, National Museum Zurich, Platzspitz – a Historic Park at the Heart of Zurich, Hans Waldmann – a Military Leader and Mayor of Zurich in the Late Middle Ages. About 70% of the visitors to the city use the tram or bus, and about half of the journeys within the municipality take place on public transport. Within Zurich and throughout the canton of Zurich, the ZVV network of public transport has traffic density ratings among the highest worldwide

Track 1: Cardiovascular Disease and Nutrition

The Cardiovascular diseases affecting the developed world have at their core atherosclerosis and hypertension, both of which are profoundly affected by diet and can be approached, at least in part, from a nutritional point of view, as can the increasing “epidemic” of obesity. Diet is a multi-component mixture of many nutrients, which may interact with one another. The definitive study of nutrients and their impact on cardiovascular disease can be a daunting enterprise. Many dietary risk factors contribute to these diseases in various environmental and ethnic settings. These risk factors are often in evidence in youth so that preventive measures must be initiated early in life.

29^th World Cardiology Conferences November 19-20, 2018, Edinburgh, Scotland; 7^th World Heart Congress August 19-20, 2019, Vienna, Austria; 31^st Annual cardiologists, June 17- 19, Rome, Italy , Acute Cardiovascular Care2019, March 02-04, 2019; 32^nd European Cardiology Conference, October 24-26, 2019, Zurich, Switzerland; EHRA 2019 March 17-19, 2019, Lisbon, Portugal; American Congress of Cardiology(ACC) March 16-18, 2019, New Orleans, USA; ESC Congress 2019, August 31 – September 04, 2019, Paris, France; Oman Health Conference & Expo, CSI Africa 2018, November 30-December 01, 2018, Cairo, Egypt; CSI Asia-Pacific 2019, February 22-24, 2019, Guangzhou, China; PreHT 2019; February 28-March 03, 2019, Vilnius, Lithuania; Heart Valve Society Annual Meeting, April 11-13, 2019, Barcelona, Spain; 4TS Conference, February 14-16, 2019, Dubai, UAE

Related Societies:

USA: The American Society for Preventive Cardiology; American Society of Nuclear Cardiology; American Heart Association; ACC; American Stroke Association; Society for Cardiovascular Angiography and Interventions; Arizona Society of Echocardiography; Brazilian Society of Cardiology; Heart Failure Society of America; Canadian Association of Cardiovascular Prevention and Rehabilitation; Elsevier Society Partners in Cardiology; American Society for Preventive Cardiology; American Society of Echocardiography; American Society of Hypertension; Brazilian Society of Hypertension; Canadian Cardiovascular Society; Argentine Society of Cardiology; Canadian Association of Interventional Cardiology; Congenital Cardiac Anesthesia Society; The American Association of Cardiovascular and Pulmonary Rehabilitation; Vascular and Endovascular Surgery Society.

Europe: European Society of Cardiology; British Cardiovascular Society; World Heart Federation; British Association for Cardiovascular Prevention and Rehabilitation; World Heart Failure Society; Austrian Heart Foundation; Austrian Society of Cardiology; Philippine Heart Association; Belgian Society of Cardiology; Spanish Society of Cardiology; British Cardiac Society; International Academy of Cardiology; British Heart Foundation; British Hypertension Society; British Junior Cardiologists Association; Croatian Cardiac Society; European Cardiology Congress; European Society of Cardiology; British cardiology society; Luxembourg Society of Cardiology; British Heart Failure Society; Association of Cardiologists of Bosnia & Herzegovina; British Heart Foundation; Spanish Heart Foundation; Austrian Heart Foundation; Belorussian Scientific Society of Cardiologists.

Asia Pacific: Asian Pacific Society of Cardiology; Cardiac Society of Australia & New Zealand; Russian Society of Cardiology; The Japanese Heart Failure Society; Japanese Society of Echocardiography; The World Society of Cardiovascular & Thoracic Surgeons; Asian Pacific Society of Hypertension; Association of Cardiologists of Kazakhstan; Australian Cardiovascular Health and Rehabilitation Association; Association of Thoracic and Cardiovascular Surgeons of Asia; Chinese Society of Cardiology; The Pan-African Society of Cardiology (PASCAR); Association of Pediatric Cardiology; Cardiological Society of India; Asian Society of Cardiovascular Imaging; Association of Black Cardiologists; Algerian Society of Hypertension; Interventional Cardiovascular Society of Malaysia; Israeli Cardiology and Critical Care Nursing Society; Japanese Society of Thoracic Radiology; Korean Society for Thoracic and Cardiovascular Surgery; Kyrgyz Society of Cardiology; Lebanese Society of Cardiology; The Heart foundation of Malaysia; The Japanese Society of Hypertension.

Track 2: Heart Diseases

Heart disease describes a range of conditions that affect the heart. Diseases under the heart disease includes blood vessel diseases, such as coronary artery disease; heart rhythm problems (arrhythmias); and heart defects you're born with (congenital heart defects), among others. Heart disease term is often used interchangeably with the cardiovascular disease. It generally refers to conditions that involve narrowed or blocked blood vessels that can lead to a heart failure, chest pain (angina) or stroke. Other heart conditions, such as those that affect your heart's muscle, valves or rhythm, also are considered forms of heart disease. Many forms of heart disease can be prevented or treated with healthy lifestyle choices.

Related Societies:

Track 3: Cardiac Nursing

Cardiac nursing is a nursing specialty which deals with the patients who suffer from various conditions of the cardiovascular system. Cardiovascular nurses handle the people with heart diseases and interact with their patients’ families. They may monitor and treat acutely ill patients, or they may focus on cardiac rehabilitation—helping patients make lifestyle changes to prevent the worsening of their disease.

Related Societies:

Track 4: Cardiac surgery

Cardiovascular surgery is the main surgery on the heart vessels. It is employed to treat the complications of valvular heart disease, ischemic heart disease or to correct congenital heart disease from various causes, endocarditis, atherosclerosis and rheumatic heart disease. It also includes heart transplantation.

Related Societies:

Track 5: Cardio-Oncology

Cardio oncology is characterized as the interdisciplinary field of medication in which the clinical adjustments of cardiovascular framework are considered amid the diverse techniques for medicines of disease. It helps in concentrate the heart conditions in patients who have been treated for malignant growth. A definitive point of Cardio oncology is to discover a harmony between oncologic viability and decreasing unfavorable cardiovascular impacts. Age, stoutness, utilization of tobacco, admission of particular kinds of malignancy medications or radiation treatment to the chest is considered as the hazard factors via cardiologists. Different reasons might be the outcomes of radio-and chemo-treatment in long haul overcomers of harm. All patients who are being considered for chemotherapy, particularly the individuals who have earlier history of heart illness ought to experience itemized cardiovascular assessment to enhance the treatment. Sequential examination of left ventricular systolic capacity and cardiovascular biomarkers may likewise be considered in the chosen populaces of patient. Harm can likewise happen amid long haul follow-up after coronary vein sidestep unite (CABG). Cardio-oncology ponders helps oncologists in early treatment by nearly viewing the core of their patients to ensure them.

Related Societies:

Track 6: Echocardiography

Electrocardiography (ECG) is the strategy for account of the electrical action of the heart over a day and age utilizing anodes set on the skin. These terminals help in the location of the moment electrical changes on the skin that emerge from the electro-physiologic example of heart muscle while depolarizing amid every heartbeat. This record called the electrocardiogram (otherwise called an ECG), gives data about the piece of the heart that triggers every heartbeat (the pacemaker called the sino-atrial hub), the nerve conduction pathways of the heart, and the pulse and cadence. For the most part, an ECG is gotten if a heart issue is suspected.

Echocardiography is alluded to as cardiovascular reverberate delivered by the ultrasound waves which thusly make the pictures of the heart. This is a kind of ultrasound test that utilizations piercing sound waves that are sent through a gadget called a transducer. The gadget gets the echoes of the sound waves as they bound with the diverse parts of your heart. These echoes will in general make moving photos of your heart that can be seen on a video screen. It distinguishes cardiomyopathies, for example, hypertrophic cardiomyopathy, widened cardiomyopathy, and numerous others.

Related Societies:

Track 7: Heart Diseases in Woman

Despite of the fact that Heart disease may regularly be thought of as an issue for men, Heart disease is the most widely recognized reason for death for the two woman and men in the United States. Luckily, ladies can find a way to comprehend their one of a kind side effects of coronary illness and to start to decrease their danger of heart disease. The pathophysiology of in people stays under scrutiny and the components in charge of the sexual dimorphism in pulse control are hazy. Sex-particular hemodynamic qualities and the impact of sex hormones may represent a portion of the distinctions. Investigations of the impacts on pulse of treatment have yielded clashing outcomes. In the WHI, ladies utilizing hormone substitution treatment had a lower commonness of hypertension (35%) than never clients (41%), yet clients would in general be more youthful and more slender. After change for these and other possibly perplexing factors, the current utilization of hormone supplanting treatment was related with a 25% expansion in the danger of hypertension contrasted and never utilize or past utilize. The and innate coronary illness have encountered impressive advancement over the most recent couple of years, with advances in new that can be connected at all phases of life from the baby to the grown-up.

Related Societies:

Track 8: Interventional Cardiology

The interventional cardiology is the main branch of cardiology that refers the specific Cather based techniques to various structural heart diseases, non-surgical procedures for treating cardiovascular disease. Interventional cardiologists use catheters; it is thin, flexible tube to repair damaged vessels or other heart structures, often avoiding the need for surgery. The most commonly procedures can be perform on heart by Catheterization. It involves the insertion of a sheath into the femoral artery and cannulating the heart under X-ray visualization. Cardiac catheterization is a test which used to evaluate the coronary arteries and heart valve function.

Related Societies:

Track 9: Pediatric Cardiology

Pediatric Cardiology is also called Pediatric Cardiopulmonary disease which involves the childhood disorder includes both the heart and lungs problems. Pediatric cardiologist is a pediatrician who has gotten broad preparing in diagnosis and treatment of kids' cardiovascular issues. Assessment and treatment may start with the embryo since heart issues can now be identified before birth.

Related Societies:

Track 10: Cardiovascular Pharmacology

Cardiovascular pharmacology is the main study of the effects of drugs on the entire cardiovascular system, which includes the heart and blood vessels.

Related Societies:

Track 11: Coronary heart diseases

Coronary heart disease is also known as the Coronary artery disease which means that the narrowing of the coronary arteries or it is a common term for the buildup of plaque inside the arteries which resize the coronary arteries. After the heart supplies blood with oxygen and nutrients, blood is carried by arteries to different body parts. The coronary arteries are vital: as coronary arteries carry blood to the heart muscle. So, when the coronary arteries become narrower then blood supply reduced to the heart muscles.

Related Societies:

Track 12: Cardiac Regeneration

The regrowth of organs and tissues of the heart that are lost in an injury are called Cardiac Regeneration. This is in disparity to wound healing, which involves closing of the injury site by forming a scar. Few tissues like skin and large organs such as liver regrow quite readily, whilst others have been seen with little or no capacity of regeneration. Nevertheless in the present research, it suggests that particularly in the Lungs and heart, there is hope for a variety of organs and tissues will eventually develop and the capacity to regenerate.

Related Societies:

Track 13: Molecular Cardiology

Molecular Cardiology is the study of genetic heart disorders. It is a new and fast-growing area of cardiovascular medicine that aims to apply molecular biology techniques for the mechanistic investigation, diagnosis, prevention, and treatment of cardiovascular disease. Gene analysis and transgenic techniques have provided a new understanding of cardiovascular disease pathogenesis.

Related Societies:

Track 14: Cardiac remodeling or Ventricular remodeling

Cardiac remodeling or Ventricular remodeling is generally accepted as a determinant of the clinical course of heart failure (HF). It defines as genome expression resulting in molecular, cellular and interstitial changes and manifested clinically as changes in shape, structure, size, and function of the heart. Cardiac remodeling can happen as a result physiological remodelling or pathological remodeling (injury to the heart muscle) and from cardiac load or injury, cardiac remodeling is influenced by hemodynamic load, neurohormonal activation. Congenital heart disease, chronic hypertension, with intra-cardiac shunting, and valvular heart disease may also lead to remodeling. Mostly the cardiac myocyte is the major cell involved in cardiac remodeling. Due to this, the myocardial necrosis (cell death) and disproportionate thinning of the heart occurs.

Related Societies:

Track 15: Vascular Biology

The Vascular Biology exists as a wide-ranging discipline that includes study of vascular function, structure, growth as well as development. This field comprises investigation at essentially all levels, including studies of molecules, cells, organs also intact organisms. Perturbations of vascular function be there involved in various pathophysiological states, with neoplasia, inflammation, aging, neurological diseases, metabolic disorders pulmonary diseases also hypertension.

Related Societies:

Track 16: Myocardial Infarction

Myocardial infarction (MI) or acute myocardial infarction (AMI), is the medical name for a heart attack. Myocardial infarction occurs when the flow of the blood stops to a part of the heart causing damage to the heart muscle. This is usually the result of a blockage in one or more of the coronary arteries. A blockage can develop due to a buildup of plaque, a substance mostly made of cholesterol, fat, and cellular waste products and the other risk factors are like smoking, obesity, diabetes, alcohol intake, high blood pressure and poor diet etc. Aspirin is an appropriate immediate treatment for a suspected myocardial infarction.

Related Societies:

Track 17: Hypertension

High blood pressure is also called hypertension and it is a serious medical condition. It happens when the force of the blood pumping through your arteries is too strong. Blood pressure is the force exerted by the blood against the blood vessels walls, and the magnitude of this force only depends on the cardiac output and the resistance of the blood vessels. The high blood pressure usually does not cause any symptoms but the long term high blood pressure, however, is a major risk factor for stroke, coronary artery disease, peripheral vascular disease, heart failure, vision loss, and chronic kidney disease. Hypertension can strain the heart, damage blood vessels, kidney problems, and increase the risk of stroke, heart attack, and death.

Related Conferences: Cardiology Conference 2019 | Cardiology Meeting | Cardiology Conferences | Cardiovascular Conferences | Cardiac Surgery Conferences | World Cardiology Congress

Related Societies:

Track 18: Clinical Cardiology

Cardiology is the branch of medicine which deals with the dysfunctions of the heart in humans or animals. The field includes diagnosis and treatment of heart failure, congenital heart defects, coronary artery disease, valvular heart disease and electrophysiology. It is a specialization of Physicians and internal medicine that specialize in this field of medicine are called cardiologists. The Cardiothoracic surgeons or Cardiac surgeons are the ones who specialize in cardiology from general surgery. Clinical Cardiology an American journal about Cardiology founded in 1978. Clinical Cardiology forum which helps in coordinating the researches in medical diagnosis, cardiovascular medicine and cardiovascular surgeries.

Related Societies:

Track 19: Cardiac Rhythm Abnormalities

Heart rhythm issues commonly called heart arrhythmias happens when the electrical motivations that arrange the heartbeats don't work appropriately, bringing about the heart to pulsate too quick, too moderate or unpredictably. Heart arrhythmias may feel like a vacillating or hustling heart and might be safe. Some heart arrhythmias may bring about annoying now and then even life-debilitating indications and signs. Heart arrhythmia treatment can regularly control quick, moderate or sporadic heartbeats. Likewise, in light of the fact that troublesome heart arrhythmias are frequently provoked or are even brought on by a harmed heart or frail, the person might have the capacity to lessen your arrhythmia hazard by receiving a heart-sound way of life.

Related Societies:

Track 20: Cardiomyopathies

Cardiomyopathy is a most common group of diseases that affect the heart muscles. In this, the heart muscle becomes rigid, enlarged or thick. In this condition, heart is less able to circulate the blood to all the body parts and maintain a normal electrical rhythm. This can lead to heart failure or irregular heartbeats called arrhythmias. In turn, heart failure can cause fluid to build up in the legs, ankles, lungs, feet or abdomen. The Typical perilous danger in patients with cardiomyopathies is sporadic heart rate.

Related Societies:

Track 21: Cardiac Diagnostic Test

The demonstrative tests in cardiology are techniques for determining the heart conditions connected with sound versus unfortunate, pathologic, heart capacity. Numerous intrusive and noninvasive tests can depict cardiovascular structure and capacity. Additionally, medications can be regulated amid certain intrusive indicative tests (e.g, percutaneous coronary intercession amid heart catheterization, radiofrequency removal amid electrophysiologic testing).

Related Societies:

Track 22: Case reports on Cardiology

Cardiology is the main part of medicine dealing with dysfunctions or malfunctioning and disorders of the heart. Heart is an important muscular organ that pumps blood to the body via circulatory system. Drugs that are used to treat all the disorders in body have a great impact on heart causing various adverse effects. Therefore, case reports on diseases and cardiac arrest have a great significance and help in development and advancing of treatment strategies. 20^th European Cardiology conference or rather all conferences of cardiology help in networking, B-2-B partnering between academicians and professionals.

Related Societies:

Track 23: Cardiometabolic Health- Diabetes, Obesity & Metabolism

The scientific goal of this track is to understand the underlying causes and pathophysiology of obesity, diabetes, and associated metabolic diseases, as well as pursuing effective and safe interventions and therapeutics. Investigators in this division also have a special emphasis on women's health and on the developmental programming of metabolic diseases. This includes expertise in the central nervous system that controls appetite and energy expenditure, pancreas function, and adipose tissue function. Our investigators utilize a broad array of research tools including non-invasive imaging, complex whole animal studies on physiology and behavior, and in vitro and ex vivo techniques.

Even though we are a small division at this time, currently consisting of 5 core scientists and 4 staff scientists, we have over $7 million (direct costs) of funding active during 2012-2013, with 70% coming from NIH and the rest from industry collaborations. Furthermore, our external collaborators have almost $2.5 million in support during that time directly related to research using our Obese NHP Resource.

Related Societies:

Track 24: Cardiac Toxicity

Cardiovascular lethality is harm to the heart by destructive synthetic concoctions. As a major aspect of your treatment, you might be given poisons (drugs) to slaughter malignant growth cells. A symptom is that the typical cells in and around your heart can likewise be killed.

Related Societies:

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 24-26, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View